CPMG Inc’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,183,603
| Closed | -$61.3M | – | 5 |
|
|
2023
Q1 | $61.3M | Hold |
6,183,603
| – | – | 12.37% | 3 |
|
|
2022
Q4 | $61.7M | Buy |
6,183,603
+2,219,962
| +56% | +$16.6M | 15.48% | 3 |
|
|
2022
Q3 | $21.8M | Buy |
3,963,641
+58,416
| +1% | +$324K | 4.28% | 4 |
|
|
2022
Q2 | $14.3M | Hold |
3,905,225
| – | – | 2.86% | 4 |
|
|
2022
Q1 | $23.6M | Buy |
3,905,225
+26,483
| +0.7% | +$161K | 3.96% | 4 |
|
|
2021
Q4 | $32.7M | Buy |
3,878,742
+683,871
| +21% | +$5.97M | 6.03% | 4 |
|
|
2021
Q3 | $28.9M | Buy |
3,194,871
+25,026
| +0.8% | +$215K | 3.19% | 4 |
|
|
2021
Q2 | $25.7M | Hold |
3,169,845
| – | – | 4.24% | 3 |
|
|
2021
Q1 | $17.5M | Buy |
3,169,845
+60,333
| +2% | +$298K | 3.34% | 3 |
|
|
2020
Q4 | $10.6M | Hold |
3,109,512
| – | – | 1.63% | 10 |
|
|
2020
Q3 | $5.25M | Buy |
3,109,512
+1,780,000
| +134% | +$2.68M | 0.87% | 12 |
|
|
2020
Q2 | $2.17M | Hold |
1,329,512
| – | – | 0.29% | 13 |
|
|
2020
Q1 | $2.55M | Buy |
1,329,512
+57,163
| +4% | +$150K | 0.44% | 10 |
|
|
2019
Q4 | $3.63M | Hold |
1,272,349
| – | – | 0.27% | 13 |
|
|
2019
Q3 | $4.19M | Hold |
1,272,349
| – | – | 0.47% | 12 |
|
|
2019
Q2 | $4.13M | Hold |
1,272,349
| – | – | 0.49% | 11 |
|
|
2019
Q1 | $4.76M | Hold |
1,272,349
| – | – | 0.57% | 12 |
|
|
2018
Q4 | $4.39M | Hold |
1,272,349
| – | – | 0.39% | 14 |
|
|
2018
Q3 | $9.12M | Hold |
1,272,349
| – | – | 0.63% | 12 |
|
|
2018
Q2 | $8.88M | Hold |
1,272,349
| – | – | 0.84% | 9 |
|
|
2018
Q1 | $7.97M | Hold |
1,272,349
| – | – | 0.89% | 9 |
|
|
2017
Q4 | $7.13M | Buy |
+1,272,349
| New | +$5.8M | 0.72% | 8 |
|
CPMG Inc's APEN Position: Q2 2023 in Review
CPMG Inc sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 6,183,603 shares — an estimated $61.3M sold.
CPMG Inc first reported a position in APEN in Q4 2017 and held it in 22 quarters. The position peaked at $61.7M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- CPMG Inc reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- CPMG Inc sold 6,183,603 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $61.3M.
- CPMG Inc first reported a position in Apollo Endosurgery, Inc. in Q4 2017 and held it in 22 quarters.
- CPMG Inc's Apollo Endosurgery, Inc. position peaked at $61.7M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on CPMG Inc's 13F filing for Q2 2023, filed 14 Aug 2023.